loading page

COVID-19 in Children with Cancer: A single Low-Middle income center experience
  • +11
  • Fatma Ebeid,
  • iman ragab,
  • nayera Elsherif,
  • Sara Makkeyah,
  • Salwa Mostafa,
  • Khadiga Eltonbary,
  • Safa Sayed,
  • Aya Mostafa ,
  • Heba AbdelRaheem,
  • Sara Agwa,
  • Hala Hafez,
  • Samia girgis,
  • Yasmin El Gendy ,
  • Manal El-Sayed
Fatma Ebeid
Ain Shams University Faculty of Medicine
Author Profile
iman ragab
Ain Shams University Faculty of Medicine
Author Profile
nayera Elsherif
Ain Shams University Faculty of Medicine
Author Profile
Sara Makkeyah
Ain Shams University Faculty of Medicine
Author Profile
Salwa Mostafa
Ain Shams University Faculty of Medicine
Author Profile
Khadiga Eltonbary
Ain Shams University Faculty of Medicine
Author Profile
Safa Sayed
Ain Shams University Faculty of Medicine
Author Profile
Aya Mostafa
Ain Shams University Faculty of Medicine
Author Profile
Heba AbdelRaheem
Ain Shams University Faculty of Medicine
Author Profile
Sara Agwa
Ain Shams University Faculty of Medicine
Author Profile
Hala Hafez
Ain Shams University Faculty of Medicine
Author Profile
Samia girgis
Ain Shams University Faculty of Medicine
Author Profile
Yasmin El Gendy
Ain Shams University Faculty of Medicine
Author Profile
Manal El-Sayed
Ain Shams University Faculty of Medicine
Author Profile

Abstract

Background: Coronavirus disease-2019 (COVID-19) could be associated with morbidity and mortality in immunocompromised children. Objective: To measure the frequency of SARS-COV-2 infection among hospitalized children with cancer and detect the associated clinical manifestations and outcomes. Methodology: A prospective non-interventional study including all hospitalized children with cancer conducted between mid-April and mid-June 2020 in Ain Shams University hospital, Egypt. Clinical, laboratory and radiological data were collected. SARS-CoV2 infection was diagnosed by RT-PCR tests in nasopharyngeal swabs. Results: Fifteen of 61 hospitalized children with cancer were diagnosed with SARS-COV-2. Their mean age was 8.3±3.5 years. Initially, 10(66.7%) were asymptomatic and 5(33.3%) were symptomatic with fever and/or cough. Baseline laboratory tests other than SARS-COV-2 RT-PCR were not diagnostic; the mean absolute lymphocyte count was 8.7±2.4 x109/L, C-reactive protein was mildly elevated in most of patients. Imaging was performed in 10(66.7%) patients with significant radiological findings detected in 4(40%) patients. Treatment was mainly supportive with antibiotics as per the febrile neutropenia protocol and local Children Hospital guidance for management of COVID-19 in children. Conclusion: Pediatric cancer patients with COVID-19 were mainly asymptomatic or with mild symptoms. A high index of suspicion and regular screening with nasopharyngeal swab in asymptomatic hospitalized cancer patients is recommended.